We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
ENI
E
$77.5B
| $1.39M | ﹤0.01% |
44,995
-323,704
| -88% | -$9.91M |
|
1252
CarMax
KMX
$8.26B
| $1.39M | ﹤0.01% |
15,862
-276,829
| -95% | -$26M |
|
1253
Puma Biotechnology
PBYI
$454M
| $1.37M | ﹤0.01% |
+156,599
| New | +$1.3M |
|
|
NSLR
1254
Neostellar Capital Corp
NSLR
$254M
| $1.37M | ﹤0.01% |
248,820
+65,405
| +36% | +$360K |
|
|
CBB
1255
DELISTED
Cincinnati Bell Inc.
CBB
| $1.37M | ﹤0.01% |
130,617
-26,848
| -17% | -$165K |
|
1256
PACCAR
PCAR
$70.1B
| $1.36M | ﹤0.01% |
25,875
+15,975
| +161% | +$822K |
|
1257
Vince Holding Corp
VNCE
$86.8M
| $1.36M | ﹤0.01% |
+78,777
| New | +$1.65M |
|
|
VIA
1258
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.36M | ﹤0.01% |
29,528
-1,796
| -6% | -$89.9K |
|
|
EXTN
1259
DELISTED
Exterran Corporation
EXTN
| $1.36M | ﹤0.01% |
173,950
+49,821
| +40% | +$462K |
|
|
PPBI
1260
DELISTED
Pacific Premier Bancorp
PPBI
| $1.36M | ﹤0.01% |
41,600
-11,534
| -22% | -$376K |
|
|
ASRT
1261
DELISTED
Assertio
ASRT
| $1.35M | ﹤0.01% |
+18,050
| New | +$1.06M |
|
1262
Cenovus Energy
CVE
$52.1B
| $1.35M | ﹤0.01% |
+133,335
| New | +$1.21M |
|
1263
Afya
AFYA
$1.27B
| $1.35M | ﹤0.01% |
+49,831
| New | +$1.34M |
|
1264
Restaurant Brands International
QSR
$25.8B
| $1.34M | ﹤0.01% |
+21,000
| New | +$1.41M |
|
1265
Stock Yards Bancorp
SYBT
$2.6B
| $1.34M | ﹤0.01% |
32,604
+23,134
| +244% | +$918K |
|
|
CURO
1266
DELISTED
CURO Group Holdings Corp.
CURO
| $1.33M | ﹤0.01% |
+109,530
| New | +$1.47M |
|
1267
Marchex
MCHX
$79.7M
| $1.32M | ﹤0.01% |
349,877
-7,520
| -2% | -$27K |
|
1268
RBB Bancorp
RBB
$455M
| $1.31M | ﹤0.01% |
+61,836
| New | +$1.26M |
|
1269
Danaher
DHR
$144B
| $1.3M | ﹤0.01% |
+9,521
| New | +$1.2M |
|
1270
National Healthcare
NHC
$3.38B
| $1.3M | ﹤0.01% |
+15,000
| New | +$1.25M |
|
|
AGS
1271
DELISTED
PlayAGS
AGS
| $1.28M | ﹤0.01% |
105,698
-10,102
| -9% | -$115K |
|
1272
Herc Holdings
HRI
$5.61B
| $1.28M | ﹤0.01% |
26,200
+21,600
| +470% | +$1.01M |
|
1273
BellRing Brands
BRBR
$1.34B
| $1.28M | ﹤0.01% |
+60,185
| New | +$1.18M |
|
1274
Peabody Energy
BTU
$2.9B
| $1.28M | ﹤0.01% |
+140,100
| New | +$1.61M |
|
|
AGEN
1275
Agenus
AGEN
$290M
| $1.27M | ﹤0.01% |
+15,915
| New | +$1.07M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.